Role of granulocytes and C5a in myocardial response to zymosan-activated serum

G. L. Stahl, M. P. Fletcher, Ezra A Amsterdam, J. C. Longhurst

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Although previous studies have demonstrated that complement (C)5a causes myocardial ischemia and mechanical dysfunction, the cardiac response of endogenously produced C5a and C5a des-Arg in zymosan-activated serum (ZAS) and the critical role of granulocytes in this process are poorly understood. Therefore, we compared the coronary and cardiac effects of ZAS and purified C5a and investigated the role of leukocyte adhesion-promoting receptors (i.e., CD11/CD18). Like purified C5a, ZAS (0.5 ml) significantly reduced coronary artery blood flow and regional segment shortening, whereas coronary venous granulocyte concentration and myocardial lactate extraction were significantly decreased. A monoclonal antibody (MoAb) to C5a/C5a des-Arg attenuated ZAS-induced cardiac alterations. Three minutes of continuous infusion of C5a or ZAS induced sustained decreases in coronary venous granulocyte concentrations, although coronary flow and segment shortening returned to control levels after 2 min. Another MoAb, IB4, directed against CD18, significantly inhibited ZAS-induced granulocyte extraction and associated cardiac effects. Thus, cardiac dysfunction occurs after activation of the complement cascade with zymosan resulting in extraction of granulocytes mediated by the CD18 adherence glycoprotein. Furthermore, intramyocardial retention of granulocytes appears necessary for the initial and full ZAS-induced cardiac dysfunction.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume261
Issue number1 30-1
StatePublished - 1991

Fingerprint

Zymosan
Granulocytes
Serum
des-Arginine Complement C5a
Leukocyte-Adhesion Receptors
Complement C5a
Monoclonal Antibodies
Complement Activation
Regional Blood Flow
Myocardial Ischemia
Lactic Acid
Coronary Vessels
Glycoproteins

Keywords

  • Adherence
  • Complement
  • Coronary blood flow
  • Ischemia
  • Leukocyte adhesion-promoting receptors
  • Monoclonal antibody IB4
  • Segment shortening

ASJC Scopus subject areas

  • Physiology

Cite this

Role of granulocytes and C5a in myocardial response to zymosan-activated serum. / Stahl, G. L.; Fletcher, M. P.; Amsterdam, Ezra A; Longhurst, J. C.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 261, No. 1 30-1, 1991.

Research output: Contribution to journalArticle

@article{45ecd7ded7cb4a5089988540b94f4dcc,
title = "Role of granulocytes and C5a in myocardial response to zymosan-activated serum",
abstract = "Although previous studies have demonstrated that complement (C)5a causes myocardial ischemia and mechanical dysfunction, the cardiac response of endogenously produced C5a and C5a des-Arg in zymosan-activated serum (ZAS) and the critical role of granulocytes in this process are poorly understood. Therefore, we compared the coronary and cardiac effects of ZAS and purified C5a and investigated the role of leukocyte adhesion-promoting receptors (i.e., CD11/CD18). Like purified C5a, ZAS (0.5 ml) significantly reduced coronary artery blood flow and regional segment shortening, whereas coronary venous granulocyte concentration and myocardial lactate extraction were significantly decreased. A monoclonal antibody (MoAb) to C5a/C5a des-Arg attenuated ZAS-induced cardiac alterations. Three minutes of continuous infusion of C5a or ZAS induced sustained decreases in coronary venous granulocyte concentrations, although coronary flow and segment shortening returned to control levels after 2 min. Another MoAb, IB4, directed against CD18, significantly inhibited ZAS-induced granulocyte extraction and associated cardiac effects. Thus, cardiac dysfunction occurs after activation of the complement cascade with zymosan resulting in extraction of granulocytes mediated by the CD18 adherence glycoprotein. Furthermore, intramyocardial retention of granulocytes appears necessary for the initial and full ZAS-induced cardiac dysfunction.",
keywords = "Adherence, Complement, Coronary blood flow, Ischemia, Leukocyte adhesion-promoting receptors, Monoclonal antibody IB4, Segment shortening",
author = "Stahl, {G. L.} and Fletcher, {M. P.} and Amsterdam, {Ezra A} and Longhurst, {J. C.}",
year = "1991",
language = "English (US)",
volume = "261",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1 30-1",

}

TY - JOUR

T1 - Role of granulocytes and C5a in myocardial response to zymosan-activated serum

AU - Stahl, G. L.

AU - Fletcher, M. P.

AU - Amsterdam, Ezra A

AU - Longhurst, J. C.

PY - 1991

Y1 - 1991

N2 - Although previous studies have demonstrated that complement (C)5a causes myocardial ischemia and mechanical dysfunction, the cardiac response of endogenously produced C5a and C5a des-Arg in zymosan-activated serum (ZAS) and the critical role of granulocytes in this process are poorly understood. Therefore, we compared the coronary and cardiac effects of ZAS and purified C5a and investigated the role of leukocyte adhesion-promoting receptors (i.e., CD11/CD18). Like purified C5a, ZAS (0.5 ml) significantly reduced coronary artery blood flow and regional segment shortening, whereas coronary venous granulocyte concentration and myocardial lactate extraction were significantly decreased. A monoclonal antibody (MoAb) to C5a/C5a des-Arg attenuated ZAS-induced cardiac alterations. Three minutes of continuous infusion of C5a or ZAS induced sustained decreases in coronary venous granulocyte concentrations, although coronary flow and segment shortening returned to control levels after 2 min. Another MoAb, IB4, directed against CD18, significantly inhibited ZAS-induced granulocyte extraction and associated cardiac effects. Thus, cardiac dysfunction occurs after activation of the complement cascade with zymosan resulting in extraction of granulocytes mediated by the CD18 adherence glycoprotein. Furthermore, intramyocardial retention of granulocytes appears necessary for the initial and full ZAS-induced cardiac dysfunction.

AB - Although previous studies have demonstrated that complement (C)5a causes myocardial ischemia and mechanical dysfunction, the cardiac response of endogenously produced C5a and C5a des-Arg in zymosan-activated serum (ZAS) and the critical role of granulocytes in this process are poorly understood. Therefore, we compared the coronary and cardiac effects of ZAS and purified C5a and investigated the role of leukocyte adhesion-promoting receptors (i.e., CD11/CD18). Like purified C5a, ZAS (0.5 ml) significantly reduced coronary artery blood flow and regional segment shortening, whereas coronary venous granulocyte concentration and myocardial lactate extraction were significantly decreased. A monoclonal antibody (MoAb) to C5a/C5a des-Arg attenuated ZAS-induced cardiac alterations. Three minutes of continuous infusion of C5a or ZAS induced sustained decreases in coronary venous granulocyte concentrations, although coronary flow and segment shortening returned to control levels after 2 min. Another MoAb, IB4, directed against CD18, significantly inhibited ZAS-induced granulocyte extraction and associated cardiac effects. Thus, cardiac dysfunction occurs after activation of the complement cascade with zymosan resulting in extraction of granulocytes mediated by the CD18 adherence glycoprotein. Furthermore, intramyocardial retention of granulocytes appears necessary for the initial and full ZAS-induced cardiac dysfunction.

KW - Adherence

KW - Complement

KW - Coronary blood flow

KW - Ischemia

KW - Leukocyte adhesion-promoting receptors

KW - Monoclonal antibody IB4

KW - Segment shortening

UR - http://www.scopus.com/inward/record.url?scp=0025823054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025823054&partnerID=8YFLogxK

M3 - Article

C2 - 1677537

AN - SCOPUS:0025823054

VL - 261

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1 30-1

ER -